Login
← Go Back
Sterling Biotech
STERLINBIO · Chemicals > Chemicals · MD: Nitin Sandesara · Listing date: May 10, 1995
Stock Price vs Company Growth
5y
16.7%
10y
16.0%
all
25.3%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 0.7 0%
N/A
0.7
Company Overview
Sales
348 Cr
Growth: -3.0%
Profit after Tax
-2,576 Cr
Growth: -7.3%
Micro Cap
19.1 Cr
P/S: 0.1x
Industry P/S: 1.5x
Fundamentals
Sales (Cr) ₹ 348
Growth -3.0%
EBITDA 9.0%
P/S 0.1x
Dividend 0.0%
P/E -0.0x
Book Value ₹ -59.7
PEG Ratio 0.0x
ROE 255.9%
P/B N/A
Shareholding Pattern
Institutions
The Bank Of New York
9.27 %
Albula Investment Fund Ltd
5.25 %
Lotus Global Investments Ltd-Adr/Gdr
5.12 %
Elara India Opportunities Fund Limited
1.64 %
Promoters
Chetan J Sandesara
1.91 %
Helicopter Service Pvt Ltd
1.83 %
Jaico Textiles Private Limited
1.77 %
Prabal Investrade Private Limited
1.44 %
Doral Trading Private Ltd
1.18 %
Others
Traub Automatics Private Limited
2.03 %
Amin Technology Services Pvt Ltd
1.84 %
Bank J Safra Sarasin Ltd
1.65 %
Softstar Merchantile Company Private Limited
1.42 %
Jitlal Financial Services Private Limited.
1.2 %
Increase    Decrease    No change
Company Profile Detailed
The company is engaged in the manufacturing of Pharma Grade Gelatine & Di-Calcium Phosphate and other Pharma products. The Company has presence in both domestic and international markets.
Investors (81)
elara.in...
nitin.sa...
blue.mar...